- Home
- ERAS vs NBR Comparison
ERAS vs NBR Comparison
Compare ERAS & NBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- NBR
- Stock Information
- Founded
- ERAS 2018
- NBR 1952
- Country
- ERAS United States
- NBR Bermuda
- Employees
- ERAS N/A
- NBR N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- NBR Oil & Gas Production
- Sector
- ERAS Health Care
- NBR Energy
- Exchange
- ERAS Nasdaq
- NBR Nasdaq
- Market Cap
- ERAS 348.4M
- NBR 417.7M
- IPO Year
- ERAS 2021
- NBR N/A
- Fundamental
- Price
- ERAS $1.45
- NBR $34.20
- Analyst Decision
- ERAS Strong Buy
- NBR Hold
- Analyst Count
- ERAS 6
- NBR 8
- Target Price
- ERAS $4.83
- NBR $44.50
- AVG Volume (30 Days)
- ERAS 1.2M
- NBR 543.5K
- Earning Date
- ERAS 08-11-2025
- NBR 07-29-2025
- Dividend Yield
- ERAS N/A
- NBR N/A
- EPS Growth
- ERAS N/A
- NBR N/A
- EPS
- ERAS N/A
- NBR N/A
- Revenue
- ERAS N/A
- NBR $2,932,608,000.00
- Revenue This Year
- ERAS N/A
- NBR $13.65
- Revenue Next Year
- ERAS N/A
- NBR $5.53
- P/E Ratio
- ERAS N/A
- NBR N/A
- Revenue Growth
- ERAS N/A
- NBR N/A
- 52 Week Low
- ERAS $1.01
- NBR $23.27
- 52 Week High
- ERAS $3.45
- NBR $105.96
- Technical
- Relative Strength Index (RSI)
- ERAS 52.19
- NBR 60.86
- Support Level
- ERAS $1.38
- NBR $33.28
- Resistance Level
- ERAS $1.58
- NBR $35.66
- Average True Range (ATR)
- ERAS 0.11
- NBR 1.99
- MACD
- ERAS 0.01
- NBR 0.44
- Stochastic Oscillator
- ERAS 64.86
- NBR 82.78
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About NBR Nabors Industries Ltd.
Nabors Industries Ltd owns and operates land-based drilling rig fleets and is a provider of offshore platform rigs in the United States and international markets. It also provides performance tools, directional drilling services, tubular running services, and technologies. The company has four reportable segments: U.S. Drilling, International Drilling, Drilling Solutions, and Rig Technologies. The key revenue of the company is generated from International Drilling.